Selected research
Market Structure
Global Gene Delivery System Technology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gene Delivery System Technology Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Gene Delivery System Technology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Delivery System Technology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Delivery System Technology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gene Delivery System Technology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gene Delivery System Technology Drug include Akcea Therapeutics, Alnylam Pharmaceuticals, AnGes, bluebird bio, Gilead Sciences, Human Stem Cells Institute, Orchard Therapeutics, Sarepta Therapeutics and SIBIONO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Gene Delivery System Technology Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Delivery System Technology Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Delivery System Technology Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Delivery System Technology Drug market size, projected growth trends, production technologies, key applications, and end-use industries.
Gene Delivery System Technology Drug Segment by Company
Akcea Therapeutics
Alnylam Pharmaceuticals
AnGes
bluebird bio
Gilead Sciences
Human Stem Cells Institute
Orchard Therapeutics
Sarepta Therapeutics
SIBIONO
Spark Therapeutics
Sunway Biotech
Amgen
Biogen
Novartis
Gene Delivery System Technology Drug Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System
Gene Delivery System Technology Drug Segment by Application
Neurological Diseases
Cancer
Other
Gene Delivery System Technology Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Delivery System Technology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Delivery System Technology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Delivery System Technology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Delivery System Technology Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Delivery System Technology Drug industry.
Chapter 3: Detailed analysis of Gene Delivery System Technology Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Delivery System Technology Drugrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Viral Gene Delivery System
- Non-viral Gene Delivery System
Applications
- Neurological Diseases
- Cancer
- Other
Companies covered
- Akcea Therapeutics
- Alnylam Pharmaceuticals
- AnGes
- bluebird bio
- Gilead Sciences
- Human Stem Cells Institute
- Orchard Therapeutics
- Sarepta Therapeutics
- SIBIONO
- Spark Therapeutics
- Sunway Biotech
- Amgen
- Biogen
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Delivery System Technology Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Viral Gene Delivery System
- 1.2.3 Non-viral Gene Delivery System
- 1.3 Market Analysis by Application
- 1.3.1 Global Gene Delivery System Technology Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Neurological Diseases
- 1.3.3 Cancer
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Gene Delivery System Technology Drug Growth Trends by Region
- 1.5.1 Global Gene Delivery System Technology Drug Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Gene Delivery System Technology Drug Market Size by Region (2021-2026)
- 1.5.3 Gene Delivery System Technology Drug Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Gene Delivery System Technology Drug Market Dynamics
- 2.1 Gene Delivery System Technology Drug Industry Trends
- 2.2 Gene Delivery System Technology Drug Industry Drivers
- 2.3 Gene Delivery System Technology Drug Industry Opportunities and Challenges
- 2.4 Gene Delivery System Technology Drug Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Gene Delivery System Technology Drug Revenue by Company (2021-2026)
- 3.2 Global Gene Delivery System Technology Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Gene Delivery System Technology Drug Key Company Head office and Area Served
- 3.4 Global Gene Delivery System Technology Drug Company, Product Type & Application
- 3.5 Global Gene Delivery System Technology Drug Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Gene Delivery System Technology Drug Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Gene Delivery System Technology Drug Players Market Share by Revenue in 2025
- 3.6.3 2025 Gene Delivery System Technology Drug Tier 1, Tier 2, and Tier 3
4 Gene Delivery System Technology Drug Market by Type
- 4.1 Global Gene Delivery System Technology Drug Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Gene Delivery System Technology Drug Market Size by Type (2021-2032)
- 4.3 Global Gene Delivery System Technology Drug Market Size Share by Type (2021-2032)
5 Gene Delivery System Technology Drug Market by Application
- 5.1 Global Gene Delivery System Technology Drug Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Gene Delivery System Technology Drug Market Size by Application (2021-2032)
- 5.3 Global Gene Delivery System Technology Drug Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Akcea Therapeutics
- 6.1.1 Akcea Therapeutics Company Information
- 6.1.2 Akcea Therapeutics Business Overview
- 6.1.3 Akcea Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Akcea Therapeutics Gene Delivery System Technology Drug Product Portfolio
- 6.1.5 Akcea Therapeutics Recent Developments
- 6.2 Alnylam Pharmaceuticals
- 6.2.1 Alnylam Pharmaceuticals Company Information
- 6.2.2 Alnylam Pharmaceuticals Business Overview
- 6.2.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product Portfolio
- 6.2.5 Alnylam Pharmaceuticals Recent Developments
- 6.3 AnGes
- 6.3.1 AnGes Company Information
- 6.3.2 AnGes Business Overview
- 6.3.3 AnGes Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 AnGes Gene Delivery System Technology Drug Product Portfolio
- 6.3.5 AnGes Recent Developments
- 6.4 bluebird bio
- 6.4.1 bluebird bio Company Information
- 6.4.2 bluebird bio Business Overview
- 6.4.3 bluebird bio Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 bluebird bio Gene Delivery System Technology Drug Product Portfolio
- 6.4.5 bluebird bio Recent Developments
- 6.5 Gilead Sciences
- 6.5.1 Gilead Sciences Company Information
- 6.5.2 Gilead Sciences Business Overview
- 6.5.3 Gilead Sciences Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Gilead Sciences Gene Delivery System Technology Drug Product Portfolio
- 6.5.5 Gilead Sciences Recent Developments
- 6.6 Human Stem Cells Institute
- 6.6.1 Human Stem Cells Institute Company Information
- 6.6.2 Human Stem Cells Institute Business Overview
- 6.6.3 Human Stem Cells Institute Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Human Stem Cells Institute Gene Delivery System Technology Drug Product Portfolio
- 6.6.5 Human Stem Cells Institute Recent Developments
- 6.7 Orchard Therapeutics
- 6.7.1 Orchard Therapeutics Company Information
- 6.7.2 Orchard Therapeutics Business Overview
- 6.7.3 Orchard Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Orchard Therapeutics Gene Delivery System Technology Drug Product Portfolio
- 6.7.5 Orchard Therapeutics Recent Developments
- 6.8 Sarepta Therapeutics
- 6.8.1 Sarepta Therapeutics Company Information
- 6.8.2 Sarepta Therapeutics Business Overview
- 6.8.3 Sarepta Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Sarepta Therapeutics Gene Delivery System Technology Drug Product Portfolio
- 6.8.5 Sarepta Therapeutics Recent Developments
- 6.9 SIBIONO
- 6.9.1 SIBIONO Company Information
- 6.9.2 SIBIONO Business Overview
- 6.9.3 SIBIONO Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 SIBIONO Gene Delivery System Technology Drug Product Portfolio
- 6.9.5 SIBIONO Recent Developments
- 6.10 Spark Therapeutics
- 6.10.1 Spark Therapeutics Company Information
- 6.10.2 Spark Therapeutics Business Overview
- 6.10.3 Spark Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Spark Therapeutics Gene Delivery System Technology Drug Product Portfolio
- 6.10.5 Spark Therapeutics Recent Developments
- 6.11 Sunway Biotech
- 6.11.1 Sunway Biotech Company Information
- 6.11.2 Sunway Biotech Business Overview
- 6.11.3 Sunway Biotech Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Sunway Biotech Gene Delivery System Technology Drug Product Portfolio
- 6.11.5 Sunway Biotech Recent Developments
- 6.12 Amgen
- 6.12.1 Amgen Company Information
- 6.12.2 Amgen Business Overview
- 6.12.3 Amgen Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Amgen Gene Delivery System Technology Drug Product Portfolio
- 6.12.5 Amgen Recent Developments
- 6.13 Biogen
- 6.13.1 Biogen Company Information
- 6.13.2 Biogen Business Overview
- 6.13.3 Biogen Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Biogen Gene Delivery System Technology Drug Product Portfolio
- 6.13.5 Biogen Recent Developments
- 6.14 Novartis
- 6.14.1 Novartis Company Information
- 6.14.2 Novartis Business Overview
- 6.14.3 Novartis Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Novartis Gene Delivery System Technology Drug Product Portfolio
- 6.14.5 Novartis Recent Developments
7 North America
- 7.1 North America Gene Delivery System Technology Drug Market Size (2021-2032)
- 7.2 North America Gene Delivery System Technology Drug Market Size by Type
- 7.2.1 North America Gene Delivery System Technology Drug Market Size by Type (2021-2026)
- 7.2.2 North America Gene Delivery System Technology Drug Market Size by Type (2027-2032)
- 7.2.3 North America Gene Delivery System Technology Drug Market Share by Type (2021-2032)
- 7.3 North America Gene Delivery System Technology Drug Market Size by Application
- 7.3.1 North America Gene Delivery System Technology Drug Market Size by Application (2021-2026)
- 7.3.2 North America Gene Delivery System Technology Drug Market Size by Application (2027-2032)
- 7.3.3 North America Gene Delivery System Technology Drug Market Share by Application (2021-2032)
- 7.4 North America Gene Delivery System Technology Drug Market Size by Country
- 7.4.1 North America Gene Delivery System Technology Drug Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Gene Delivery System Technology Drug Market Size by Country (2021-2026)
- 7.4.3 North America Gene Delivery System Technology Drug Market Size by Country (2027-2032)
- 7.4.4 North America Gene Delivery System Technology Drug Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Gene Delivery System Technology Drug Market Size (2021-2032)
- 8.2 Europe Gene Delivery System Technology Drug Market Size by Type
- 8.2.1 Europe Gene Delivery System Technology Drug Market Size by Type (2021-2026)
- 8.2.2 Europe Gene Delivery System Technology Drug Market Size by Type (2027-2032)
- 8.2.3 Europe Gene Delivery System Technology Drug Market Share by Type (2021-2032)
- 8.3 Europe Gene Delivery System Technology Drug Market Size by Application
- 8.3.1 Europe Gene Delivery System Technology Drug Market Size by Application (2021-2026)
- 8.3.2 Europe Gene Delivery System Technology Drug Market Size by Application (2027-2032)
- 8.3.3 Europe Gene Delivery System Technology Drug Market Share by Application (2021-2032)
- 8.4 Europe Gene Delivery System Technology Drug Market Size by Country
- 8.4.1 Europe Gene Delivery System Technology Drug Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Gene Delivery System Technology Drug Market Size by Country (2021-2026)
- 8.4.3 Europe Gene Delivery System Technology Drug Market Size by Country (2027-2032)
- 8.4.4 Europe Gene Delivery System Technology Drug Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Gene Delivery System Technology Drug Market Size (2021-2032)
- 9.2 China Gene Delivery System Technology Drug Market Size by Type
- 9.2.1 China Gene Delivery System Technology Drug Market Size by Type (2021-2026)
- 9.2.2 China Gene Delivery System Technology Drug Market Size by Type (2027-2032)
- 9.2.3 China Gene Delivery System Technology Drug Market Share by Type (2021-2032)
- 9.3 China Gene Delivery System Technology Drug Market Size by Application
- 9.3.1 China Gene Delivery System Technology Drug Market Size by Application (2021-2026)
- 9.3.2 China Gene Delivery System Technology Drug Market Size by Application (2027-2032)
- 9.3.3 China Gene Delivery System Technology Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Gene Delivery System Technology Drug Market Size (2021-2032)
- 10.2 Asia Gene Delivery System Technology Drug Market Size by Type
- 10.2.1 Asia Gene Delivery System Technology Drug Market Size by Type (2021-2026)
- 10.2.2 Asia Gene Delivery System Technology Drug Market Size by Type (2027-2032)
- 10.2.3 Asia Gene Delivery System Technology Drug Market Share by Type (2021-2032)
- 10.3 Asia Gene Delivery System Technology Drug Market Size by Application
- 10.3.1 Asia Gene Delivery System Technology Drug Market Size by Application (2021-2026)
- 10.3.2 Asia Gene Delivery System Technology Drug Market Size by Application (2027-2032)
- 10.3.3 Asia Gene Delivery System Technology Drug Market Share by Application (2021-2032)
- 10.4 Asia Gene Delivery System Technology Drug Market Size by Country
- 10.4.1 Asia Gene Delivery System Technology Drug Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Gene Delivery System Technology Drug Market Size by Country (2021-2026)
- 10.4.3 Asia Gene Delivery System Technology Drug Market Size by Country (2027-2032)
- 10.4.4 Asia Gene Delivery System Technology Drug Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Type
- 11.2.1 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Gene Delivery System Technology Drug Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Application
- 11.3.1 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Gene Delivery System Technology Drug Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Country
- 11.4.1 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Gene Delivery System Technology Drug Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst